News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
166,830 Results
Type
Article (6739)
Company Profile (79)
Press Release (160012)
Multimedia
Podcasts (7)
Webinars (1)
Section
Business (56674)
Career Advice (176)
Deals (11538)
Drug Delivery (10)
Drug Development (20525)
Employer Resources (24)
FDA (3596)
Job Trends (3564)
News (89752)
Policy (6780)
Tag
Academia (621)
Accelerated approval (3)
Adcomms (1)
Allergies (38)
Alliances (8079)
ALS (24)
Alzheimer's disease (351)
Antibody-drug conjugate (ADC) (44)
Approvals (3649)
Artificial intelligence (46)
Autoimmune disease (9)
Automation (4)
Bankruptcy (57)
Best Places to Work (3182)
Biosimilars (26)
Biotechnology (63)
Bladder cancer (41)
Brain cancer (10)
Breast cancer (121)
Cancer (930)
Cardiovascular disease (70)
Career advice (155)
Career pathing (4)
CAR-T (55)
CDC (5)
Cell therapy (118)
Cervical cancer (9)
Clinical research (17499)
Collaboration (173)
Compensation (152)
Complete response letters (7)
COVID-19 (938)
CRISPR (10)
C-suite (44)
Cystic fibrosis (19)
Data (1107)
Depression (19)
Diabetes (111)
Diagnostics (1700)
Digital health (7)
Diversity, equity & inclusion (6)
Drug discovery (30)
Drug pricing (17)
Drug shortages (1)
Duchenne muscular dystrophy (31)
Earnings (40817)
Editorial (9)
Employer branding (4)
Employer resources (21)
Events (26326)
Executive appointments (82)
FDA (4243)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (187)
Gene editing (26)
Generative AI (3)
Gene therapy (84)
GLP-1 (251)
Government (1262)
Grass and pollen (3)
Guidances (277)
Healthcare (5388)
HIV (8)
Huntington's disease (8)
IgA nephropathy (11)
Immunology and inflammation (46)
Immuno-oncology (6)
Indications (12)
Infectious disease (974)
Inflammatory bowel disease (34)
Inflation Reduction Act (2)
Influenza (12)
Intellectual property (29)
Interviews (26)
IPO (7917)
IRA (5)
Job creations (535)
Job search strategy (136)
Kidney cancer (4)
Labor market (22)
Layoffs (126)
Leadership (4)
Legal (1071)
Liver cancer (17)
Lung cancer (162)
Lymphoma (94)
Machine learning (1)
Management (5)
Manufacturing (82)
MASH (33)
Medical device (3812)
Medtech (3816)
Mergers & acquisitions (3795)
Metabolic disorders (245)
Multiple sclerosis (37)
NASH (5)
Neurodegenerative disease (32)
Neuropsychiatric disorders (14)
Neuroscience (539)
NextGen: Class of 2025 (1303)
Non-profit (1066)
Now hiring (7)
Obesity (105)
Opinion (25)
Ovarian cancer (18)
Pain (18)
Pancreatic cancer (36)
Parkinson's disease (33)
Partnered (5)
Patents (55)
Patient recruitment (55)
Peanut (24)
People (8507)
Pharmaceutical (14)
Pharmacy benefit managers (2)
Phase I (4637)
Phase II (7532)
Phase III (6834)
Pipeline (1297)
Policy (23)
Postmarket research (608)
Preclinical (1654)
Press Release (12)
Prostate cancer (52)
Psychedelics (4)
Radiopharmaceuticals (125)
Rare diseases (111)
Real estate (865)
Recruiting (12)
Regulatory (5164)
Reports (17)
Research institute (465)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (1)
RSV (16)
Schizophrenia (27)
Series A (22)
Series B (19)
Service/supplier (5)
Sickle cell disease (21)
Special edition (6)
Spinal muscular atrophy (49)
Sponsored (8)
Startups (543)
Stomach cancer (4)
Supply chain (9)
Tariffs (16)
The Weekly (6)
Vaccines (160)
Venture capital (10)
Weight loss (69)
Women's health (6)
Worklife (1)
Date
Last 7 days (105)
Last 30 days (395)
Last 365 days (7838)
2025 (5609)
2024 (9256)
2023 (10008)
2022 (11970)
2021 (31695)
2020 (19917)
2019 (10088)
2018 (7140)
2017 (6708)
2016 (5809)
2015 (7089)
2014 (4812)
2013 (3602)
2012 (3801)
2011 (4407)
2010 (4362)
Location
Africa (118)
Alabama (11)
Alaska (2)
Arizona (37)
Arkansas (3)
Asia (9995)
Australia (1172)
California (2002)
Canada (773)
China (185)
Colorado (110)
Connecticut (84)
Delaware (88)
Europe (23908)
Florida (278)
Georgia (88)
Idaho (13)
Illinois (200)
India (11)
Indiana (142)
Japan (72)
Kansas (21)
Kentucky (7)
Louisiana (6)
Maine (26)
Maryland (262)
Massachusetts (1486)
Michigan (73)
Minnesota (120)
Mississippi (1)
Missouri (15)
Montana (6)
Nebraska (1)
Nevada (21)
New Hampshire (18)
New Jersey (739)
New Mexico (2)
New York (550)
North Carolina (278)
Northern California (982)
Ohio (52)
Oklahoma (1)
Oregon (12)
Pennsylvania (514)
Puerto Rico (2)
Rhode Island (4)
South America (203)
South Carolina (2)
Southern California (710)
Tennessee (44)
Texas (252)
United States (7648)
Utah (73)
Virginia (33)
Washington D.C. (11)
Washington State (183)
Wisconsin (16)
166,830 Results for "22".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross Proceeds
September 18, 2025
·
5 min read
Press Releases
Enveric Biosciences Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds
September 19, 2025
·
5 min read
Vaccines
RFK Jr. Axes 22 mRNA Vaccine Projects Under BARDA
The Department of Health and Human Services is terminating around $500 million in BARDA contracts associated with mRNA vaccine development, a move that will affect several pharma companies, including Moderna, Pfizer, Sanofi and AstraZeneca.
August 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Omeros Corporation Announces Pricing of $22 Million Registered Direct Offering
July 28, 2025
·
4 min read
Press Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - August 22, 2025
August 24, 2025
·
3 min read
Press Releases
IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025
July 2, 2025
·
2 min read
Press Releases
Gynecological Devices Market Size is Forecast to Hit USD 23.22 Bn by 2034
July 8, 2025
·
1 min read
Press Releases
Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting
September 17, 2025
·
2 min read
Press Releases
Lilly’s Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with type 2 diabetes
September 18, 2025
·
21 min read
Press Releases
Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025
June 23, 2025
·
1 min read
1 of 16,683
Next
